| |
|
|
Painreform Ltd (NASDAQ: PRFX) |
|
|
|
|
Painreform Ltd's Operating Profit Margin, Return on Sales by quarter
Trends, Rankings, Statistics
|
Select the Comparisons :
|
|
Select the Ratio:
|
Operating Profit Margin, Return on Sales ▼
|
Operating Profit Margin, Return on Sales ▼
|
| PRFX Operating Profit Margin, Return on Sales |
(Dec 31 2024)
Q4 |
0
Q3 |
0
Q2 |
0
Q1 |
(Dec 31 2022)
Q4 |
| Y / Y Revenue Change |
- |
- |
- |
- |
- |
| Seq. Revenue Change |
- |
- |
- |
- |
- |
| Revenue In Millions |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Profit Margin, Return on Sales |
- |
- |
- |
- |
- |
| Operating Profit Margin, Return on Sales Total
Ranking |
# |
# |
# |
# |
# |
| Operating Income In Millions |
$-14.67 |
$0.00 |
$0.00 |
$0.00 |
$-8.87 |
| Y / Y Operating Income Change |
- |
- |
- |
- |
- |
| Seq. Operating Income Change |
- |
- |
- |
- |
- |
| PRFX's Operating Profit Margin, Return on Sales fourth quarter 2024 Company Ranking |
| Within: |
No. |
| Major Pharmaceutical Preparations Industry |
# |
| Healthcare Sector |
# |
| Overall |
# 0 |
| Operating Profit Margin, Return on Sales Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| Companies with similar Operating Profit Margin, Return on Sales in the quarter ending Dec 31 2024, within Major Pharmaceutical Preparations Industry | Operating Profit Margin, Return on Sales | Dec 31 2024 MRQ Operating Income | Dec 31 2024 MRQ Revenue |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
